May 28, 2020

Oncopeptides reinitiates patient enrollment to the melflufen clinical program following a temporary pause due to the COVID-19 pandemic

May 28, 2020 - Regulatory press release Press releases STOCKHOLM — May 28, 2020 — Oncopeptides AB (Nasdaq Stockholm: ONCO) announces that the company starts pa...
Read more
May 27, 2020

BONESUPPORT has completed a directed share issue raising SEK 378 million

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, ISRAEL, JAPAN,...
Read more
May 26, 2020

BONESUPPORT intends to carry out a directed share issue

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, ISRAEL, JAPAN,...
Read more
May 26, 2020

Bulletin from the Annual General Meeting in Oncopeptides AB (publ)

Stockholm, Sweden – 26 May 2020 – Oncopeptides AB (publ)’s (ONCO) Annual General Meeting 2020 was held today, at Tändstickspalatset in Stockholm. At the Annual General...
Read more
May 26, 2020

Interim Report Q1 2020

May 26, 2020 -  Regulatory press release Summary Financial overview January 1 – March 31, 2020 Net sales amounted to SEK 0.0 M (0.0) Loss for the period wa...
Read more
May 26, 2020

Nordic Nanovector ASA: Results for the First Quarter 2020

Oslo, Norway, 26 May 2020 Nordic Nanovector ASA (OSE: NANO) announces its results for the first quarter 2020. A presentation by Nordic Nanovector's senior management t...
Read more
May 22, 2020

Oncopeptides completes enrollment to the pivotal phase 3 study OCEAN for relapsed refractory multiple myeloma – 450 patients included

STOCKHOLM — May 22, 2020 — Oncopeptides AB (Nasdaq Stockholm: ONCO) announces a successful completion of enrollment in the pivotal phase 3 study OCEAN for the treatment o...
Read more
May 21, 2020

Carisma Therapeutics to Present and Meet with Potential Investors at Upcoming Healthcare Investor Conferences

PHILADELPHIA, May 21, 2020 /PRNewswire/ -- Carisma Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announce...
Read more
May 20, 2020

Bulletin from the Annual General Meeting of Vicore Pharma Holding AB (publ)

2020-05-20 The following resolutions were passed at the annual general meeting (the “AGM”) of Vicore Pharma Holding AB (publ) on 20 May 2020. Adoption of income statement...
Read more
May 20, 2020

Strongbridge Biopharma plc Announces $30 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.

DUBLIN, Ireland and TREVOSE, Pa., May 20, 2020 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on t...
Read more